Brief: A1M Pharma Q3 operating loss widens to SEK 18.3 mln
Nov 22 (Reuters) - A1M PHARMA AB A1M.ST :
* Q3 OPERATING LOSS SEK 18.3 MILLION VERSUS LOSS SEK 14.4
MILLION
YEAR AGO
Source text for Eikon: ID:nBQNbTFPbL
Further company coverage: A1M.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover